business

Eli Lilly (LLY) Announces Positive Phase 3 Results for Jaypirca Combination in Relapsed CLL/SLL

Yahoo Finance · Jun 27, 2026, 11:21 AM · Also reported by 2 other sources

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com Lilly’s Jaypirca receives positive EU regulatory opinion for CLL Investing.com ProQR reports positive Phase 1 data for AX-0810 in healthy volunteers

Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Eli Lilly (LLY) Announces Positive Phase 3 Results for Jaypirca Combination in Relapsed CLL/SLL

Also covered by

More in business